AbbVie partnered with Anima Biotech to discover and develop mRNA modulators in a collaboration of up to $582 million. The partnership will focus on three oncology and immunology targets.
https://www.pharmalive.com/wp-content/uploads/2022/04/BioSpaceAbbVie.jpg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2023-01-10 09:52:182023-01-10 09:52:18AbbVie, Anima strike mRNA deal worth up to $582 million
